Literature DB >> 32965512

Quantitative assessment of brachial plexus MRI for the diagnosis of chronic inflammatory neuropathies.

Marieke H J van Rosmalen1,2, H Stephan Goedee3, Anouk van der Gijp2, Theo D Witkamp2, Ruben P A van Eijk1,4, Fay-Lynn Asselman1, Leonard H van den Berg1, Stefano Mandija5,6, Martijn Froeling2, Jeroen Hendrikse2, W Ludo van der Pol1.   

Abstract

OBJECTIVE: This study aimed at developing a quantitative approach to assess abnormalities on MRI of the brachial plexus and the cervical roots in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN) and to evaluate interrater reliability and its diagnostic value.
METHODS: We performed a cross-sectional study in 50 patients with CIDP, 31 with MMN and 42 disease controls. We systematically measured cervical nerve root sizes on MRI bilaterally (C5, C6, C7) in the coronal [diameter (mm)] and sagittal planes [area (mm2)], next to the ganglion (G0) and 1 cm distal from the ganglion (G1). We determined their diagnostic value using a multivariate binary logistic model and ROC analysis. In addition, we evaluated intra- and interrater reliability.
RESULTS: Nerve root size was larger in patients with CIDP and MMN compared to controls at all predetermined anatomical sites. We found that nerve root diameters in the coronal plane had optimal reliability (intrarater ICC 0.55-0.87; interrater ICC 0.65-0.90). AUC was 0.78 (95% CI 0.69-0.87) for measurements at G0 and 0.81 (95% CI 0.72-0.91) for measurements at G1. Importantly, our quantitative assessment of brachial plexus MRI identified an additional 10% of patients that showed response to treatment, but were missed by nerve conduction (NCS) and nerve ultrasound studies.
CONCLUSION: Our study showed that a quantitative assessment of brachial plexus MRI is reliable. MRI can serve as an important additional diagnostic tool to identify treatment-responsive patients, complementary to NCS and nerve ultrasound.

Entities:  

Keywords:  Brachial plexus; Chronic inflammatory demyelinating polyneuropathy; Diagnostic value; Magnetic resonance imaging; Multifocal motor neuropathy

Mesh:

Year:  2020        PMID: 32965512      PMCID: PMC7914242          DOI: 10.1007/s00415-020-10232-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Diagnostic usefulness of plexus magnetic resonance imaging in chronic inflammatory demyelinating polyradiculopathy without electrodiagnostic criteria of demyelination.

Authors:  G Fargeot; K Viala; M Theaudin; M-A Labeyrie; R Costa; J M Léger; D Adams; C Vandendries; C Labeyrie
Journal:  Eur J Neurol       Date:  2018-12-10       Impact factor: 6.089

3.  Diagnostic value of sonography in treatment-naive chronic inflammatory neuropathies.

Authors:  H Stephan Goedee; W Ludo van der Pol; Jan-Thies H van Asseldonk; Hessel Franssen; Nicolette C Notermans; Alexander J F E Vrancken; Michael A van Es; Stavros Nikolakopoulos; Leo H Visser; Leonard H van den Berg
Journal:  Neurology       Date:  2016-12-07       Impact factor: 9.910

4.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

5.  CIDP diagnostic pitfalls and perception of treatment benefit.

Authors:  Jeffrey A Allen; Richard A Lewis
Journal:  Neurology       Date:  2015-07-15       Impact factor: 9.910

6.  MRI of enlarged dorsal ganglia, lumbar nerve roots, and cranial nerves in polyradiculoneuropathies.

Authors:  M Castillo; S K Mukherji
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

7.  Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies.

Authors:  Pierre Lozeron; Marie-Christine Lacour; Christophe Vandendries; Marie Théaudin; Cécile Cauquil; Christian Denier; Catherine Lacroix; David Adams
Journal:  J Neurol Sci       Date:  2015-11-27       Impact factor: 3.181

Review 8.  Nerve ultrasound and magnetic resonance imaging in the diagnosis of neuropathy.

Authors:  H Stephan Goedee; W Ludo van der Pol; Jeroen Hendrikse; Leonard H van den Berg
Journal:  Curr Opin Neurol       Date:  2018-10       Impact factor: 5.710

9.  Multimodal magnetic resonance imaging of peripheral nerves: Establishment and validation of brachial and lumbosacral plexi measurements in 163 healthy subjects.

Authors:  Xiaoyun Su; Xiangquan Kong; Dingxi Liu; Xiangchuang Kong; Osamah Alwalid; Jing Wang; Shenglei Shu; Chuansheng Zheng
Journal:  Eur J Radiol       Date:  2019-05-24       Impact factor: 3.528

10.  Low interrater reliability of brachial plexus MRI in chronic inflammatory neuropathies.

Authors:  Marieke H J van Rosmalen; H Stephan Goedee; Anouk van der Gijp; Theo D Witkamp; Martijn Froeling; Jeroen Hendrikse; W Ludo van der Pol
Journal:  Muscle Nerve       Date:  2020-02-21       Impact factor: 3.217

View more
  3 in total

1.  MRI of the intraspinal nerve roots in patients with chronic inflammatory neuropathies: abnormalities correlate with clinical phenotypes.

Authors:  W Ludo van der Pol; H Stephan Goedee; Marieke H J van Rosmalen; Martijn Froeling; Stefano Mandija; Jeroen Hendrikse
Journal:  J Neurol       Date:  2022-01-06       Impact factor: 4.849

2.  Nerve ultrasound may help predicting response to immune treatment in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Jingwen Niu; Lei Zhang; Jing Fan; Jingwen Liu; Qingyun Ding; Yuzhou Guan; Shuang Wu; Liying Cui; Mingsheng Liu
Journal:  Neurol Sci       Date:  2022-01-21       Impact factor: 3.307

3.  The Application of Contrast-Enhanced 3D-STIR-VISTA MR Imaging of the Brachial Plexus.

Authors:  Dingsheng Han; Yanru Zhou; Lan Zhang; Jiajia Zhang
Journal:  J Belg Soc Radiol       Date:  2022-09-05       Impact factor: 1.912

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.